DiamondRock guided 2026 adjusted FFO to $1.12-$1.18 per share. FactSet's consensus sat at $0.89. That's a 29% gap at the midpoint, which is the kind of variance that makes you ask whether the analysts were covering a different company.

They weren't. They were covering the old one. DRH spent the last two years recycling urban assets into leisure and lifestyle resorts, targeting 50%+ of EBITDA from resort properties by this year. Q1 2026 showed the strategy delivering: comparable RevPAR up 2.0% to $190.01, total RevPAR up 2.5% to $298.95, and hotel operating expenses growing less than 1%. That expense discipline is the line that matters. RevPAR growth with flat costs means expanding margins, and expanding margins are what flow through to FFO. The $0.22 per diluted share in Q1 beat the $0.19 estimate by 15.8%. So the full-year raise wasn't a surprise to anyone actually reading the quarterly filings.

The Courtyard Manhattan/Fifth Avenue sale announced May 4 is worth decomposing. $33.0 million for 189 keys. That's $174,600 per key for a leasehold interest (not fee simple) at a 13.3% cap rate on 2025 NOI. A 13.3% cap rate on a Manhattan select-service tells you exactly what the buyer thinks about the asset's trajectory... ground lease escalations, union labor cost pressure, and a PIP cycle that would have eaten into returns. DRH took the $0.025 per share FFO hit and moved on. That's rational capital allocation. You sell the asset where your cost to hold exceeds your return to hold. The $300 million share repurchase authorization announced April 28 tells you where they think the capital works harder.

What's interesting is the structural story the consensus missed. DRH redeemed preferred stock in December 2025, adding roughly $0.03 per share to AFFO. They renewed their insurance program April 1 at favorable terms (insurance is one of those line items that can swing 20-40 basis points of margin and rarely gets modeled correctly by sell-side analysts who've never run a hotel P&L). Resort comparable RevPAR grew 3.6% in Q1 with out-of-room spending averaging $320 per night... more than triple the urban portfolio. When your revenue mix shifts toward assets that generate three times the ancillary spend, the old model breaks.

The 29% guidance gap isn't a story about DRH outperforming. It's a story about consensus estimates failing to capture a portfolio that fundamentally changed its risk and return profile over 24 months. No debt maturities until 2029. Resort-weighted EBITDA. Expense growth under 1%. The $1.15 midpoint represents a record for the company and 6.5% growth year-over-year. Analysts will revise upward now. They should have revised six months ago.

Pebblebrook posted $0.51 FFO per diluted share against a $0.50 consensus estimate, and the stock just hit a 52-week high at $14.33. Revenue came in at $398.7 million, a 1.4% year-over-year decline that missed the Street's $400.6 million target by $1.9 million. Net loss: negative $32.4 million. Same-property RevPAR fell 1.5%, which "outperformed" the estimated decline of 2.3%. Outperforming a negative estimate is still negative.

Let's decompose the capital structure. PEB refinanced $400 million in convertible notes due 2026 into new 1.625% convertibles due 2030, buying them back at a 2% discount to par. That's smart liability management. But there's still $350 million in convertibles maturing December 2026. Net debt to trailing EBITDA sits at 6.1x. For context, most lodging REIT analysts start getting uncomfortable north of 5.0x. PEB's weighted-average interest rate of 4.1% is genuinely low for the sector, but a 6.1x leverage ratio on declining RevPAR is not a comfortable place to build a growth thesis. The $50 million in share repurchases during Q3 signals management believes the stock is cheap... or that organic investment opportunities aren't compelling enough to deploy that capital elsewhere. Both readings are instructive.

The dividend tells you everything the FFO beat doesn't. $0.01 per common share, quarterly. That's $0.04 annualized on a stock trading at $14.33. A 0.28% yield. I audited a management company once where the owner kept asking why the P&L looked healthy but his distributions kept shrinking. The answer was always the same: the operating metrics were fine, but the capital stack was consuming the cash. PEB's $65-75 million annual cap-ex run rate, combined with the remaining $350 million in convertible maturities, explains why a company generating $99.2 million in quarterly adjusted EBITDAre is paying its common shareholders essentially nothing.

The market mix underneath the RevPAR decline matters more than the headline. San Francisco and Chicago showed strength. Los Angeles and D.C. dragged. PEB owns 44 hotels across 13 markets, which means portfolio-level RevPAR obscures property-level dispersion. A portfolio averaging negative 1.5% RevPAR growth could easily contain properties at positive 8% and properties at negative 12%. The Zacks upgrade to "strong-buy" on April 15 presumably reflects the thesis that PEB's $525 million redevelopment program positions the portfolio for rate recovery. That thesis requires RevPAR to inflect positive and stay there long enough to de-lever.

The question I'd ask before the Q1 2026 call on April 28: what does RevPAR look like in the markets where PEB deployed the heaviest redevelopment capital, and has the rate premium materialized relative to comp set? If $525 million in repositioning spend hasn't moved the RevPAR index meaningfully above 100 in those markets, the capital allocation thesis needs revisiting. The stock can hit 52-week highs on sentiment. The owner's return is determined by cash flow after the capital stack takes its share... and right now, that share is substantial.

Pebblebrook's full-year 2026 guidance projects Adjusted FFO per diluted share of $1.50 to $1.62. The midpoint is $1.56. They printed $1.58 in 2025. That's a company telling you, at the midpoint, that per-share cash flow might decline year-over-year... while simultaneously guiding Same-Property Total RevPAR growth of 2.25% to 4.25%. RevPAR up, FFO flat-to-down. That's a cost story, and the Q1 call on April 29 is where we find out how bad.

Let's decompose the 2025 results. Net loss of ($62.2) million, which included $48.9 million in impairment charges from dispositions. Strip those out and the operating picture improves, but not enough to celebrate. Same-Property Hotel EBITDA was $348.2 million. The 2026 Adjusted EBITDAre guidance of $325 to $339 million is lower, even at the top end. That's a 2.6% decline at best. The company completed a $525 million redevelopment program and is stepping down to $65-$75 million in normalized capex. So they've spent the money. Now they need the return. Q1 will be the first real read on whether those redeveloped assets are producing.

The balance sheet move in February was smart. New $450 million unsecured term loan maturing 2031, extended the $650 million revolver, paid off the 2027 term loan and the Hollywood Beach mortgage. That's a company clearing near-term maturities and buying runway. The question is what they need the runway for. If urban recovery in San Francisco, Chicago, and Portland accelerates, this looks like disciplined capital management. If those markets stall (and D.C. and San Diego stay soft), it looks like a company creating breathing room because it needs it.

Thirteen analysts cover this stock. Six say sell. Five say hold. One buy, one strong buy. Average target: $11.91. The stock is at $12.04. The market is telling you that Pebblebrook is fairly valued at best and possibly overvalued by consensus. The preferred shares are a different story (trading at a 20%+ discount with 5.7x coverage on 2025 Adjusted FFO), but that's a fixed-income trade, not an equity thesis. For the common, you need to believe urban full-service demand accelerates meaningfully in 2026. The guidance itself doesn't make that case.

The April 29 call matters more than usual. Not for the EPS number (consensus is $0.19-$0.23, and they'll probably beat it the way they beat Q4 by $0.08). What matters is the Same-Property RevPAR detail by market, the margin trajectory after $525 million in redevelopment, and whether management adjusts the full-year range. A company guiding to a possible net loss of ($10.4) million at the low end while growing RevPAR 2-4% is telling you that cost pressures are real and the redevelopment ROI hasn't fully materialized. If Q1 margins compress, the full-year EBITDA number is at risk... and at $325 million on the low end, that's barely covering the capital structure.

Pebblebrook reported $1.58 in Adjusted FFO per diluted share for 2025, $0.05 above the midpoint of its own outlook. Same-Property Hotel EBITDA came in at $348.2 million, $2.2 million above guidance. The stock price tells you the market doesn't care. PEB has been trading around $11 for months. The company repurchased 6.3 million shares at an average of $11.37. Management says that's an attractive discount to NAV. The question is whether management is right about the NAV.

Let's decompose what happened. The net loss of $62.2 million includes $48.9 million in impairment charges from hotel dispositions. That's not operational failure. That's the accounting reality of selling hotels below their book value. Pebblebrook generated $116.3 million in disposition proceeds in Q4 alone and used $100 million of that to pay down debt. They also closed a new $450 million unsecured term loan maturing in 2031, replacing a $360 million facility due in 2027. The balance sheet is getting cleaner. But cleaner isn't the same as stronger (my parents ran a small business... I learned early that paying off one bill by selling the furniture works exactly once).

The 2026 guidance is where it gets interesting. Adjusted FFO per share of $1.50 to $1.62. The midpoint is $1.56. That's lower than 2025's $1.58. Same-Property Total RevPAR growth of 2.25% to 4.25%. Adjusted EBITDAre of $325 to $339 million, down from $342.5 million in 2025. Net income range of negative $10.4 million to positive $3.6 million. Management is guiding to lower EBITDA year-over-year while projecting RevPAR growth. That gap needs explaining. Part of it is the reduced portfolio from dispositions. Part of it is $65 to $75 million in capital investments. But the flow-through question remains: if RevPAR grows 3% and EBITDA shrinks, where is the money going?

Q4 2025 offers a clue. Same-Property Total RevPAR grew 2.9%, driven by occupancy gains and 5.5% growth in out-of-room revenues. The out-of-room number is the one I'd watch. Pebblebrook has been repositioning toward urban and resort lifestyle assets with higher ancillary revenue potential. That strategy works when you can staff F&B outlets and programming. It breaks when labor costs eat the incremental revenue. The 35% jump in Q4 Adjusted FFO per share looks impressive until you realize it's partly a function of a smaller share count from buybacks, not just operational improvement. Buybacks at a discount to NAV can be accretive. Buybacks that mask flat operating performance are a different story.

The real number here is the implied cap rate on recent dispositions. $116.3 million in Q4 proceeds across two hotels. Without per-property detail, I can't decompose precisely, but Pebblebrook has been selling assets in markets they're exiting (West Coast urban, primarily) at prices that generated impairment charges. That means they're selling below book. They're calling it portfolio optimization. An owner I talked to once put it differently: "I'm making money for everyone except myself." The management company collects fees on the way up and the way down. The REIT investor absorbs the write-down. If you own PEB, the question isn't whether the strategy is directionally correct. It probably is. The question is whether you'll still own it long enough for the repositioned portfolio to deliver.

Host Hotels & Resorts trades at roughly $319K per key across its 41,700-room portfolio. Adjusted FFO hit $2.07 per share for full-year 2025, up 3.5% from $2.00 the prior year. Five analysts raised price targets in the last 30 days. The consensus says "Outperform." The 55.09% one-year total shareholder return says the market agrees.

The number worth decomposing is the disposition strategy. Host is selling the Four Seasons Orlando and Four Seasons Jackson Hole in Q1 2026. Both are luxury assets with significant future CapEx requirements. That's a capital recycling decision... sell the properties where the next dollar of maintenance spend has declining marginal return, redeploy into acquisitions or buybacks where the return per dollar is higher. On paper, textbook REIT discipline. The 13.3% jump in Q4 adjusted FFO per share (from $0.45 to $0.51) suggests the operating portfolio is generating enough growth to absorb the lost NOI from dispositions. But "enough growth to absorb" and "enough growth to compound" are different thresholds.

Here's what the price target convergence around $20 tells you. UBS at $20, Barclays at $20, Argus at $20. Three firms landing on the same number with different ratings (Neutral, Equal-Weight, Buy) means they agree on the valuation but disagree on whether that valuation represents opportunity or fair price. Truist and Ladenburg at $23 are pricing in a growth assumption the $20 crowd isn't. The spread between $20 and $23 is the market's uncertainty about whether Host's urban and resort demand recovery has a second leg or has already been captured in the stock.

The 4.3% dividend yield on an $0.80 annual payout looks solid until you stress-test it. At $2.07 FFO per share, the payout ratio is 38.6%. That's conservative, which is good. But if RevPAR growth in Host's core luxury and upper-upscale markets softens by even 200-300 basis points, FFO compression hits the buyback capacity before it hits the dividend. The question nobody's modeling: what happens to the capital recycling thesis when the bid-ask spread on luxury hotel dispositions widens in a rising-rate environment? You can't recycle capital if buyers aren't pricing assets where you need them.

I've analyzed portfolios with this exact profile before... strong trailing performance, smart dispositions, conservative balance sheet, consensus upgrades. The analysis always looks cleanest at the top of the cycle. The $20 price target crowd is telling you something the $23 crowd isn't ready to say out loud. Check again.